Triple A syndrome (TAS) is a rare autosomal recessive disorder first described in 1978 [1], characterized by the classical triad of adrenocorticotropic hormone (ACTH)-resistant adrenal insufficiency [2], alacrimia (absence of tear production) and achalasia. This evidence concerns the gene POMC and Triple A syndrome.